Literature DB >> 28716670

Nationwide study on peripheral-venous-catheter-associated-bloodstream infections in internal medicine departments.

M Guembe1, M J Pérez-Granda2, J A Capdevila3, J Barberán4, B Pinilla5, P Martín-Rabadán6, E Bouza7.   

Abstract

BACKGROUND: The use of peripheral venous catheters (PVCs) has increased outside intensive care units, as has the rate of PVC-associated-bloodstream infection (PVC-BSI). PVCs are widely used in internal medicine departments (IMDs), but data on the incidence of PVC-BSI and its characteristics in IMDs are scarce. AIM: To assess the incidence of PVC-BSI episodes detected in IMDs in Spain.
METHODS: A one-year multi-centre prospective observational cohort study in 14 Spanish IMDs was undertaken. Adult patients admitted with at least one PVC and bacteraemia were included in the study. Demographic and clinical data were provided by local coordinators.
FINDINGS: Seventy episodes of PVC-BSI were recorded, representing an overall rate of 1.64 PVC-BSI episodes/1000 IMD admissions. The mean age of patients was 67.44 (standard deviation 16.72) years. It was estimated that 25.7% of PVCs were no longer necessary. Staphylococcus aureus was the most frequently isolated micro-organism (41.7%). Phlebitis was clinically evident in 44 (62.9%) episodes, and proved to be an independent predictor of catheter insertion in emergency departments (odds ratio 5.44). The crude and attributable mortality rates were 12.9% and 5.7%, respectively.
CONCLUSIONS: PVCs carry a significant risk for bacteraemia in Spanish IMDs. Phlebitis is not always clinically evident in patients with bacteraemia in this population. The study findings support the need for educational and interventional preventive measures in both IMDs and emergency departments to reduce the rate of PVC-BSI and associated comorbidities, and costs.
Copyright © 2017 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bacteraemia; Internal medicine departments; Peripheral venous catheter; Peripheral-venous-catheter-associated bloodstream infection; Phlebitis; Prevalence; Staphylococcus aureus

Mesh:

Year:  2017        PMID: 28716670     DOI: 10.1016/j.jhin.2017.07.008

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  10 in total

1.  Short-Term Peripheral Venous Catheter-Related Bloodstream Infections: Evidence for Increasing Prevalence of Gram-Negative Microorganisms from a 25-Year Prospective Observational Study.

Authors:  Marco Ripa; Laura Morata; Olga Rodríguez-Núñez; Celia Cardozo; Pedro Puerta-Alcalde; Marta Hernández-Meneses; Juan Ambrosioni; Laura Linares; Marta Bodro; Andrea Valcárcel; Climent Casals; Maria de Los Angeles Guerrero-León; Manel Almela; Carolina Garcia-Vidal; Ana Del Río; Francesc Marco; Josep Mensa; José Antonio Martínez; Alex Soriano
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

2.  Risk Factors and Outcomes Associated With Hospital-Onset Peripheral Intravenous Catheter-Associated Staphylococcus aureus Bacteremia.

Authors:  Mica Blauw; Betsy Foxman; Juan Wu; Janice Rey; Neelay Kothari; Anurag N Malani
Journal:  Open Forum Infect Dis       Date:  2019-02-27       Impact factor: 3.835

3.  Inhibition of bacterial attachment and biofilm formation by a novel intravenous catheter material using an in vitro percutaneous catheter insertion model.

Authors:  Rahul Pathak; Steve F Bierman; Pieter d'Arnaud
Journal:  Med Devices (Auckl)       Date:  2018-12-19

Review 4.  Possible clinical indications of ceftobiprole.

Authors:  J Barberán
Journal:  Rev Esp Quimioter       Date:  2019-09       Impact factor: 1.553

5.  Clinical characteristics of peripheral venous catheter-associated gram-negative bloodstream infection among patients with malignancy.

Authors:  Toshiharu Sasaki; Sohei Harada; Shungo Yamamoto; Daisuke Ohkushi; Brian Hayama; Koichi Takeda; Kosuke Hoashi; Joji Shiotani; Kazumi Takehana; Yohei Doi
Journal:  PLoS One       Date:  2020-01-30       Impact factor: 3.240

6.  Usability Assessment of an Innovative Device in Infusion Therapy: A Mix-Method Approach Study.

Authors:  Pedro Parreira; Liliana B Sousa; Inês A Marques; Paulo Santos-Costa; Sara Cortez; Filipa Carneiro; Arménio Cruz; Anabela Salgueiro-Oliveira
Journal:  Int J Environ Res Public Health       Date:  2020-11-11       Impact factor: 3.390

7.  Hospital-acquired infections caused by enterococci: a systematic review and meta-analysis, WHO European Region, 1 January 2010 to 4 February 2020.

Authors:  Simon Brinkwirth; Olaniyi Ayobami; Tim Eckmanns; Robby Markwart
Journal:  Euro Surveill       Date:  2021-11

8.  Trends in the epidemiology of catheter-related bloodstream infections; towards a paradigm shift, Spain, 2007 to 2019.

Authors:  Laia Badia-Cebada; Judit Peñafiel; Patrick Saliba; Marta Andrés; Jordi Càmara; Dolors Domenech; Emili Jiménez-Martínez; Anna Marrón; Encarna Moreno; Virginia Pomar; Montserrat Vaqué; Enric Limón; Úrsula Masats; Miquel Pujol; Oriol Gasch
Journal:  Euro Surveill       Date:  2022-05

9.  Comment on: Cannula complications using elastomeric infusers in Hospital in the Home.

Authors:  Hugh G Dickson; Evan Alexandrou; Jayanthi Ramanathan; Dana West
Journal:  JAC Antimicrob Resist       Date:  2020-10-22

10.  Randomized clinical trial analyzing maintenance of peripheral venous catheters in an internal medicine unit: Heparin vs. saline.

Authors:  María Jesús Pérez-Granda; Emilio Bouza; Blanca Pinilla; Raquel Cruces; Ariana González; Jesús Millán; María Guembe
Journal:  PLoS One       Date:  2020-01-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.